{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "TWD", "marketState": "POSTPOST", "regularMarketChangePercent": -2.5723472, "regularMarketPrice": 151.5, "exchange": "TWO", "shortName": "LBS", "longName": "Lin BioScience, Inc.", "messageBoardId": "finmb_557089042", "exchangeTimezoneName": "Asia/Taipei", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "market": "tw_market", "esgPopulated": false, "regularMarketTime": 1684133987, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -4.3, "sharesOutstanding": 72439000, "bookValue": 20.018, "fiftyDayAverage": 185.81, "fiftyDayAverageChange": -34.309998, "fiftyDayAverageChangePercent": -0.18465097, "twoHundredDayAverage": 185.6175, "twoHundredDayAverageChange": -34.117493, "twoHundredDayAverageChangePercent": -0.18380538, "marketCap": 11152097280, "priceToBook": 7.5681887, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1538960400000, "priceHint": 2, "regularMarketChange": -4.0, "regularMarketDayHigh": 155.5, "regularMarketDayRange": "149.0 - 155.5", "regularMarketDayLow": 149.0, "regularMarketVolume": 208957, "regularMarketPreviousClose": 155.5, "bid": 149.5, "ask": 151.5, "bidSize": 0, "askSize": 0, "fullExchangeName": "Taipei Exchange", "financialCurrency": "TWD", "regularMarketOpen": 155.5, "averageDailyVolume3Month": 432139, "averageDailyVolume10Day": 326007, "fiftyTwoWeekLowChange": 12.0, "fiftyTwoWeekLowChangePercent": 0.086021505, "fiftyTwoWeekRange": "139.5 - 245.5", "fiftyTwoWeekHighChange": -94.0, "fiftyTwoWeekHighChangePercent": -0.38289204, "fiftyTwoWeekLow": 139.5, "fiftyTwoWeekHigh": 245.5, "symbol": "6696.TWO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 68, Zhongxiao East Road", "address2": "12th Floor Section 5 Xinyi District", "city": "Taipei", "zip": "110", "country": "Taiwan", "phone": "886 2 8780 5008", "fax": "886 2 8780 5038", "website": "https://www.linbioscience.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Lin BioScience, Inc., a drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases. Its product pipeline includes LBS-008, an oral therapy for dry age-related macular degeneration (Dry AMD)and stargardt diseases (STGD1), which is under Phase 3 clinical trial to evaluate safety and efficacy in adolescent STGD1 and under phase 2 or phase 3 clinical trial to evaluate safety and efficacy in Dry AMD; LBS-007, a natural non-ATP CDC7 inhibitor for the treatment of cancers; LBS-002, an anti-tubulin to treat primary and metastatic brain tumors; and LBS-009, an oral therapy for the treatment of non-alcoholic fatty liver disease and type 2 diabetes. The company is headquartered in Taipei, Taiwan.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Yu-Hsin  Lin M.B.A., Ph.D.", "age": 43, "title": "Chairman & CEO", "yearBorn": 1979, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Zhengqi  Wang M.B.A., Ph.D.", "title": "Pres & CSO", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Serena  Chen", "title": "Fin. Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Hongwei  Chen", "title": "Chief Operating Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}